Literature DB >> 21276342

Primary care diagnostic technology update: point-of-care testing for glycosylated haemoglobin.

Annette Plüddemann1, Christopher P Price, Matthew Thompson, Jane Wolstenholme, Carl Heneghan.   

Abstract

CLINICAL QUESTION: In the monitoring of patients with type 1 and type 2 diabetes, what advantages does point-of-care HbA(1c) testing provide over current practice?

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21276342      PMCID： PMC3026154          DOI： 10.3399/bjgp11X556290

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


  11 in total

Review 1.  Near patient testing in diabetes clinics: appraising the costs and outcomes.

Authors:  R Grieve; R Beech; J Vincent; J Mazurkiewicz
Journal:  Health Technol Assess       Date:  1999       Impact factor: 4.014

2.  Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study.

Authors:  Christopher C Patterson; Gisela G Dahlquist; Eva Gyürüs; Anders Green; Gyula Soltész
Journal:  Lancet       Date:  2009-05-27       Impact factor: 79.321

3.  Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria.

Authors:  Erna Lenters-Westra; Robbert J Slingerland
Journal:  Clin Chem       Date:  2009-11-19       Impact factor: 8.327

4.  Possibilities and advantages with home sampling of HbA1c: eight years experience.

Authors:  K Snellman; S Eckerbom
Journal:  Diabet Med       Date:  1997-05       Impact factor: 4.359

5.  Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.

Authors:  E Cagliero; E V Levina; D M Nathan
Journal:  Diabetes Care       Date:  1999-11       Impact factor: 19.112

6.  Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus.

Authors:  Kamlesh Khunti; Margaret A Stone; Andrew C Burden; David Turner; Neil T Raymond; Mary Burden; Richard Baker
Journal:  Br J Gen Pract       Date:  2006-07       Impact factor: 5.386

7.  Rapid A1c availability improves clinical decision-making in an urban primary care clinic.

Authors:  Christopher D Miller; Catherine S Barnes; Lawrence S Phillips; David C Ziemer; Daniel L Gallina; Curtiss B Cook; Sandra D Maryman; Imad M El-Kebbi
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

8.  Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction.

Authors:  M A Stone; A C Burden; M Burden; R Baker; K Khunti
Journal:  Diabet Med       Date:  2007-04-19       Impact factor: 4.359

Review 9.  Screening for type 2 diabetes: literature review and economic modelling.

Authors:  N Waugh; G Scotland; P McNamee; M Gillett; A Brennan; E Goyder; R Williams; A John
Journal:  Health Technol Assess       Date:  2007-05       Impact factor: 4.014

10.  Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial.

Authors:  Tanya K Bubner; Caroline O Laurence; Angela Gialamas; Lisa N Yelland; Philip Ryan; Kristyn J Willson; Philip Tideman; Paul Worley; Justin J Beilby
Journal:  Med J Aust       Date:  2009-06-01       Impact factor: 7.738
View more
  3 in total

1.  Impact of Monthly A1C Values Obtained at Home on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Authors:  Andreina Millan-Ferro; Gabriela Garcia-Dolagaray; Shiva Gautam; A Enrique Caballero; Joanna Mitri
Journal:  Clin Diabetes       Date:  2020-07

2.  Opportunities and challenges of a novel cardiac output response to stress (CORS) test to enhance diagnosis of heart failure in primary care: qualitative study.

Authors:  Sarah Charman; Nduka Okwose; Gregory Maniatopoulos; Sara Graziadio; Tamara Metzler; Helen Banks; Luke Vale; Guy A MacGowan; Petar M Seferović; Ahmet Fuat; Christi Deaton; Jonathan Mant; Richard F D Hobbs; Djordje G Jakovljevic
Journal:  BMJ Open       Date:  2019-04-14       Impact factor: 2.692

Review 3.  Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent.

Authors:  M Larissa Avilés-Santa; Alberto Monroig-Rivera; Alvin Soto-Soto; Nangel M Lindberg
Journal:  Curr Diab Rep       Date:  2020-10-10       Impact factor: 4.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.